HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Weili Zhang Selected Research

ginsenoside Rb2

1/2021Ginsenoside Rb2 Alleviated Atherosclerosis by Inhibiting M1 Macrophages Polarization Induced by MicroRNA-216a.
1/2021Inhibitory role of ginsenoside Rb2 in endothelial senescence and inflammation mediated by microRNA‑216a.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Weili Zhang Research Topics

Disease

13Neoplasms (Cancer)
03/2021 - 06/2010
8Stroke (Strokes)
07/2019 - 03/2006
7Atherosclerosis
01/2021 - 03/2006
6Inflammation (Inflammations)
01/2022 - 07/2010
5Infections
05/2022 - 01/2010
4Myocardial Infarction
08/2022 - 07/2010
4Hypertension (High Blood Pressure)
01/2019 - 01/2008
4Urinary Bladder Neoplasms (Bladder Cancer)
05/2011 - 09/2009
3Colorectal Neoplasms (Colorectal Cancer)
11/2022 - 07/2011
3Atherosclerotic Plaque (Atheroma)
01/2020 - 03/2013
3Multiple Sclerosis
01/2018 - 08/2014
3Breast Neoplasms (Breast Cancer)
10/2016 - 08/2014
3Cardiomegaly (Heart Hypertrophy)
06/2014 - 01/2008
3Coronary Artery Disease (Coronary Atherosclerosis)
11/2011 - 08/2010
3Heart Failure
10/2011 - 06/2010
2Lung Neoplasms (Lung Cancer)
06/2022 - 10/2019
2Pain (Aches)
01/2022 - 01/2019
2Asthma (Bronchial Asthma)
01/2022 - 01/2021
2Prostatic Neoplasms (Prostate Cancer)
03/2021 - 01/2018
2Ischemic Stroke
07/2019 - 04/2013
2Aortic Dissection
04/2017 - 03/2006
2Essential Hypertension
01/2017 - 07/2011
2Fibrosis (Cirrhosis)
06/2015 - 11/2011
2Non-Muscle Invasive Bladder Neoplasms
12/2014 - 02/2011
2Bacterial Infections (Bacterial Infection)
12/2013 - 01/2010
2Urinary Tract Infections (Urinary Tract Infection)
12/2013 - 01/2010
2Cardiovascular Diseases (Cardiovascular Disease)
08/2010 - 06/2009
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
08/2010 - 01/2008
2Coronary Disease (Coronary Heart Disease)
08/2007 - 03/2006
1Neoplasm Metastasis (Metastasis)
11/2022
1Lymphoma (Lymphomas)
06/2022
1Leukemia
06/2022
1Gastrointestinal Hemorrhage (Hematochezia)
06/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022
1Heterotopic Ossification (Ectopic Ossification)
01/2022
1Hyperuricemia
01/2022
1Intervertebral Disc Displacement (Herniated Disc)
01/2022
1Diabetic Neuropathies (Diabetic Neuropathy)
01/2022
1Hip Osteoarthritis (Coxarthrosis)
01/2022
1Bronchitis
08/2021
1Necrosis
08/2021
1Dyspnea (Shortness of Breath)
08/2021
1Cryptococcosis
04/2021
1Chronic Disease (Chronic Diseases)
01/2021
1Intraoperative Complications
01/2021
1Osteoarthritis
01/2021
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2021
1Pneumonia (Pneumonitis)
01/2021
1Mycoses (Diseases, Fungus)
05/2020

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
06/2022 - 04/2013
5Genetic Markers (Genetic Marker)IBA
01/2022 - 03/2006
4Long Noncoding RNAIBA
06/2022 - 03/2019
4Messenger RNA (mRNA)IBA
06/2022 - 06/2010
4MicroRNAs (MicroRNA)IBA
01/2022 - 07/2011
4Pharmaceutical PreparationsIBA
01/2019 - 08/2014
4Proteins (Proteins, Gene)FDA Link
01/2019 - 03/2006
3CytokinesIBA
01/2022 - 09/2017
3Phosphotransferases (Kinase)IBA
01/2019 - 08/2007
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 08/2007
3teriflunomideIBA
01/2018 - 08/2014
2Carbapenems (Carbapenem Antibiotics)IBA
05/2022 - 09/2017
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 11/2011
2Uric Acid (Urate)IBA
01/2022 - 11/2009
2Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 09/2011
2DiureticsIBA
01/2022 - 09/2011
2Apolipoproteins E (ApoE)IBA
01/2021 - 04/2013
2LipidsIBA
01/2021 - 04/2013
2ginsenoside Rb2IBA
01/2021 - 01/2021
2NanogelsIBA
03/2019 - 01/2019
2ApolipoproteinsIBA
01/2019 - 04/2013
2Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
01/2019 - 10/2009
2Vitamin K Epoxide ReductasesIBA
01/2019 - 03/2006
2Estrogens (Estrogen)FDA Link
04/2015 - 08/2014
2Caspase 3 (Caspase-3)IBA
12/2014 - 06/2010
2ORALIT (ORS)IBA
04/2013 - 02/2011
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
08/2009 - 08/2007
1Indicators and Reagents (Reagents)IBA
11/2022
1Purinergic P1 Receptors (Adenosine Receptor)IBA
08/2022
1GlucocorticoidsIBA
06/2022
1Interleukin-17 (Interleukin 17)IBA
06/2022
1ceftazidime drug combination avibactamIBA
05/2022
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2022
1Interleukin-10 (Interleukin 10)IBA
01/2022
1mouse MIRN29 microRNAIBA
01/2022
1Voltage-Gated Sodium ChannelsIBA
01/2022
1KinesinsIBA
01/2022
1PlasticsIBA
08/2021
1Pattern Recognition ReceptorsIBA
04/2021
1dectin 1IBA
04/2021
1CoagulaseIBA
01/2021
1TaurineFDA Link
01/2021
1PeriostinIBA
01/2021

Therapy/Procedure

12Therapeutics
11/2022 - 06/2010
2Drug Therapy (Chemotherapy)
11/2022 - 01/2022
2Length of Stay
08/2021 - 05/2020
2Carotid Endarterectomy
01/2020 - 03/2013
1Catheters
06/2022
1Nephrectomy
01/2021
1Artificial Respiration (Mechanical Ventilation)
05/2020
1Liver Transplantation
05/2020